The Pharma Letter
PrivateLast Round
Series A
Extension
May 14, 2026
Total Funding Raised
$135M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
The Pharma Letter is a media company that provides high-value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries.
Sector
Media, Entertainment & Gaming
Verticals
Digital Publishing, News & Media, Digital Advertising, Podcasts
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Freemium
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
The Pharma Letter Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
The Pharma Letter Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 14, 2026 | ||||
| Series A Extension | May 14, 2026 | ||||
| Series A | Jun 9, 2022 |
The Pharma Letter Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series A |
| Baidu Ventures | Series A |
| Co-Win Ventures | Series A, Seed |
| YuanBio Venture Capital | Series A, Seed |
| GF Xinde Investment Management | Series A Extension |
| Lapam Capital | Series A Extension |
| Zhongke Chuangxing | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$40M round led by Lapam Capital.
- May 14, 2026
$40M round led by Lapam Capital.
The Pharma Letter Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about The Pharma Letter's valuation, stock price, and market status.